Lunit signs a distribution agreement for AI imaging software with Salud Digna

South Korean AI company Lunit has partnered with Mexican medical network Salud Digna to distribute its AI-based image analysis software to more than 230 clinical sites in Mexico and Central America.

The agreement includes Lunit’s INSIGHT MMG for mammography diagnostics and analysis and INSIGHT CXR, a chest X-ray analysis software that recently demonstrated superior performance in tuberculosis (TB) detection in an independent study.

In the study, published in The Lancet Digital HealthINSIGHT CXR achieved the highest accuracy among 12 AI-based TB detection products tested. The software demonstrated a sensitivity of 89.9% at a specificity of 67.7% and a sensitivity of 89.5% at a specificity of 70.2%, which met the World Health Organization (WHO) target product profile.

Lunit said the partnership means Salud Digna’s network physicians will have the ability to perform faster, more accurate imaging analysis while gaining access to Salud Digna’s extensive database of anonymized medical images, which it will use to refine AI algorithms that are specifically tailored to the Latin American market.

Furthermore, unlike typical partnerships of this nature, Lunit stated that it will also collaborate with Salud Digna on research projects aimed at further developing AI for medical imaging to improve healthcare across the region.

Salud Digna CEO Juan Carlos Ordoñez said: “By integrating Lunit’s advanced AI into our healthcare network, we aim to improve the accuracy and efficiency of our imaging services.

“Together, we want to leverage our extensive data resources to drive innovation in medical imaging and ultimately improve patient care across the region.”

In 2022, Lunit achieved a CE mark under the EU’s revised Medical Device Regulation (MDR) and a UK Conformity Assessed (UKCA) mark for Lunit INSIGHT, its suite of AI solutions for radiology, becoming the first software as medical tool (SaMD) company in the Asia Pacific region to do this.

GlobalData’s 2023 AI in Healthcare report predicts that AI platforms in healthcare will reach a global value of $18.8 billion by 2027.

“Lunit Signs Distribution Agreement for AI Imaging Software with Salud Digna” was originally created and published by Medical Device Network, a brand owned by GlobalData.

The information on this site has been included in good faith for general information purposes only. It is not intended to amount to advice on which reliance should be placed and we make no representation, warranty or guarantee, express or implied, as to its accuracy or completeness. You must obtain professional or specialist advice before taking or refraining from any action on the basis of the content on our site.